Sponsored Content
In this special series, Tom Johnson, owner of TJ BioTech, tackles questions about optimizing trunk-injection applications to treat HLB.
Q: What does the special local need label for ReMedium TI® mean for citrus growers heading into next season?
Tom Johnson: TJ BioTech recently requested a ReMedium TI® label change from the Florida Department of Agriculture and Consumer Services. The label change request was specifically about the resistance management section of that label that required a third year of no ReMedium TI® injection after two consecutive years of oxytetracycline (OTC) injections. The change request was granted by removing the two-year restriction of the label.
In other words, if a tree or grove has been injected for two years, the previous label restricted a ReMedium TI® injection in a third consecutive year. That restriction had raised a significant amount of concern about taking an injection year off. A year off of ReMedium TI® may be detrimental to the citrus greening recovery the industry has seen over the past two years.
The removal of the third-year restriction is great news for the citrus industry and for continued recovery of trees that have been devastated by greening over the past couple of decades.
Resistance management is still important to the longevity of ReMedium TI® use in the industry. Therefore, TJ BioTech is continuing research that is designed to provide a management plan to preserve the positive impact of ReMedium TI® far into the future.
Tom Johnson is the owner of TJ BioTech, the manufacturer of ReMedium TI®. If you have a question about trunk injection, please send it to citrusindustry@agnetmedia.com.
Share this Post
Sponsored Content